Evaluating the efficacy and safety of Anlotinib in conjunction with stereotactic radiosurgery for small cell lung cancer patients with brain metastases
Anlotinib combined with SRT significantly alleviates brain edema, reduces the incidence of radiation-induced brain necrosis, enhances intracranial progression-free survival, and demonstrates a low adverse reaction rate.
Authors
- Ying Ji (ORCID: https://orcid.org/0000-0002-2252-429X)
- Zejing Qu
- Guizhi Yu
- Yanping Cui
- Lizhi Wang
- Huilin Sun
Institutions
- Affiliated Hospital of Chengde Medical College (CN)
- Chengde Medical University (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2024-08-26
- DOI
- https://doi.org/10.32604/or.2024.051586
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00